Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

NCT03680092 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

GVHD
Hematologic Neoplasms

Interventions

DRUG: Cyclophosphamide
DRUG: abatacept
DRUG: Methotrexate
DRUG: Tacrolimus

Sponsor

Dimitrios Tzachanis, MD PhD

Collaborators

[object Object]